Skip to main content

H23 (Minocycline Hydrochloride Extended-Release 135 mg)

Pill with imprint H23 is Brown, Elliptical/Oval and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Global Pharmaceuticals.

Minocycline is used in the treatment of bacterial infection; acne; actinomycosis; bartonellosis; periodontitis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for H23

Minocycline hydrochloride extended-release 135 mg H23

Minocycline Hydrochloride Extended-Release

Imprint
H23
Strength
135 mg
Color
Brown
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
National Drug Code (NDC)
00115-1247 (Discontinued)
Inactive Ingredients
lactose monohydrate, hypromelloses, magnesium stearate, titanium dioxide, triacetin, polydextrose, polyethylene glycol, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "H23"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.